C3-R - Corneal Collagen Crosslinking with Riboflavin Kucukcekmece

Corneal Collagen Crosslinking with Riboflavin (CXL) Corneal collagen crosslinking is a safe, minimally invasive procedure designed to stabilize and strengthen the cornea in patients experiencing progressive keratoconus or corneal ectasia. The procedure involves applying riboflavin (Vitamin B2) eye drops combined with controlled ultraviolet (UV-A) light exposure to reinforce corneal fibers. Procedure Steps: Preparation: The eye is numbed using topical anesthetic drops to ensure patient comfort. Epithelium Removal (if applicable): The corneal surface layer (epithelium) may be gently removed to allow optimal riboflavin absorption. Riboflavin Application: Riboflavin drops are applied at regular intervals for approximately 30 minutes to saturate the cornea. UV-A Exposure: The cornea is exposed to controlled UV-A light for around 10-30 minutes, activating the riboflavin to facilitate collagen crosslinking. Completion: A protective contact lens may be placed to promote healing and comfort post-procedure. Recovery: Patients typically experience mild discomfort, sensitivity to light, and blurred vision initially, but these symptoms usually improve within a few days. Prescribed eye drops are used to aid healing and prevent infection. Benefits: CXL significantly slows or stops keratoconus progression, preserves vision, reduces the risk of corneal transplantation, and improves overall corneal stability. Risks: Although generally safe, potential complications include temporary irritation, light sensitivity, corneal haze, or infection. Such complications are rare and usually manageable.

Glaucoma Surgical Treatment Glaucoma surgery is a safe and effective treatment designed to lower intraocular pressure (IOP) and preserve vision in patients diagnosed with glaucoma. Surgical interventions typically aim to enhance the drainage of fluid (aqueous humor) from the eye or reduce fluid production, helping prevent further damage to the optic nerve. Procedure Steps: Preparation: Your eye will be numbed with anesthetic drops, and sedation may be administered to help you relax. Incision and Drainage Creation: The surgeon makes a small incision in the eye and creates a new drainage channel (trabeculectomy) or implants a tiny drainage device (glaucoma drainage implant or stent) to enhance fluid outflow. Fluid Regulation: The newly created pathway helps control fluid drainage, effectively lowering intraocular pressure. Completion: The incision site may be sutured or left to self-seal, depending on the specific procedure. Recovery: Post-surgery recovery typically involves the use of prescribed eye drops to control inflammation and prevent infection. Most patients experience stabilized or improved intraocular pressure within a few weeks. Regular follow-up appointments are crucial to monitor eye pressure and ensure successful healing. Benefits: Glaucoma surgery significantly reduces the risk of vision loss and optic nerve damage by effectively managing eye pressure and preserving visual function. Risks: While generally successful, potential risks include infection, bleeding, changes in vision, or increased cataract formation. These complications are rare and usually manageable with appropriate treatment.